Cypress Capital Group ABBV Holdings History
Cypress Capital Group's AbbVie Inc Holding Summary
As of 2025-03-31, Cypress Capital Group held 107,592.00 shares of AbbVie Inc(ABBV), totaling $22.54 Mil. This investment constitutes 2.95% of their stock portfolio, and Cypress Capital Group now holds 0.01% of the outstanding AbbVie Inc(ABBV) stock.
The initial trade took place in 2014Q1. And since then Cypress Capital Group has made 12 purchases of ABBV, at an average price of $63.55, for a total of 211,766.00 shares. In addition, there have been 24 sales at an average price of $111.59 for 104,174.00 shares. Based on historical transaction data and ABBV's current price of $189.77, Cypress Capital Group's estimated gain on his ABBV holdings is $18.58 Mil, reflecting a 138.09% gain to date.
Cypress Capital Group ABBV ($189.77) Holding Chart
Cypress Capital Group ABBV ($189.77) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
